KLRK1 and neoplasm: In addition, more and more researches pointed out that NKG2D and its ligands are also exploited as tumor survival assets, enabling immune evasion and suppression, and quite possibly stimulation of tumor growth and malignant progression 31, 32, 33, 34, 35, 36.